Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Allegro Merger Corp.

CIK: 17200253 Annual ReportsLatest: 2026-02-11

10-K / February 11, 2026

Revenue:N/A
Income:-$72,705

10-K / March 14, 2025

Revenue:N/A
Income:-$39,479

10-K / March 26, 2024

Revenue:N/A
Income:-$38,673

10-K / February 11, 2026

Allegro Acquisition Corp

Purpose and business model

  • Delaware corporation formed on August 7, 2017 to complete an initial public offering and pursue a business combination (merger, acquisition, or similar transaction) with one or more target businesses.
  • Current plan is to identify, investigate, and, if warranted, acquire one or more operating businesses or entities, with a focus on long-term growth rather than short-term earnings.
  • No agreements or understandings with any potential merger candidate as of the date of the filing; multiple potential targets may be considered but capital is limited.
  • If a merger is completed, the company expects to be merged into or become a subsidiary of the target. SeeQC’s IPO is planned to occur simultaneously with the merger if the SeeQC path is pursued.

History of capital raises and liquidity

  • Completed an IPO of 14,950,000 units at $10 each (including over-allotment) and a concurrent private placement of 372,500 private placement units, for gross proceeds of $149,500,000 and $3,725,000, respectively.
  • Proceeds from the IPO and private placement were placed in a Trust Account.
  • Delayed or canceled merger plans led to dissolution-related activities: public shares redeemed in 2020; remaining restricted cash distributed in 2021.
  • Initial stockholders provided loans totaling $781,700 that may be forgiven if no merger occurs.
  • As of December 31, 2025, cash balance was $98 and working capital deficit was $1,077,352.

Current operating status (as of 12/31/2025)

  • No operating history and no revenue.
  • No employees.
  • No material ongoing business operations beyond evaluating and pursuing a merger.
  • 4,110,000 shares of common stock remained outstanding after certain waivers.

Securities and related matters

  • Previously listed on Nasdaq and later delisted; securities are not traded on any established market.
  • Warrants and rights issued in the IPO and private placements include features such as:
    • Potential redemption by the company at $0.01 per warrant under certain stock-price conditions.
    • Rights and warrants may be amended with 65% holder approval.
    • Registration rights granted to initial stockholders and private placement holders, which may affect the market for the common stock.
  • Warrant accounting was restated following SEC guidance; warrants are accounted for as liabilities with ongoing fair value measurement. The restatement generated additional costs and required management resources.

Planned strategic transaction (SeeQC)

  • On January 16, 2026, the company entered into a merger agreement with SeeQC, Inc. and Merger Sub, Inc. under which Merger Sub would merge into the company, with the company surviving as a direct, wholly-owned subsidiary of SeeQC.
  • Simultaneous with the merger, SeeQC intends to pursue an initial public offering of its common stock (the SeeQC IPO).
  • The merger, the SeeQC IPO, and related transactions are expected to close in the first half of 2026, subject to the conditions in the merger agreement.
  • If the transactions with SeeQC do not occur, the company may pursue a different strategic transaction.

Governance, risk, and regulatory context

  • The company reports going-concern uncertainties related to cash and liquidity deficits.
  • A material weakness in internal controls over financial reporting was identified related to warrant accounting.
  • The company faces competition in identifying merger targets and potential conflicts of interest among officers, directors, and affiliated entities.
  • Regulatory and compliance costs of maintaining public company status may affect operations and costs.
  • Penny stock designation and lack of an on-market trading platform may affect liquidity and capital-raising ability.

Financial snapshot (as of 12/31/2025)

  • Cash balance: $98
  • Working capital deficit: $1,077,352
  • Revenue: none
  • Employees: 0
  • Outstanding common shares: 4,110,000
  • Trust Account funds were largely distributed during the dissolution process; loans from initial stockholders may be forgiven if no merger occurs.

Operational implications

  • The company is currently pursuing a merger opportunity as its primary business activity.
  • Future value depends on completing a merger transaction (with SeeQC or another target) and any resulting integration, financing, and regulatory approvals.
  • Past accounting restatements and liquidity challenges may affect investor confidence and future capital-raising efforts.